In this study, we found an increase in plasma levels of leptin and OPG, and a decrease in levels of OC, OPN, SOST, PTH and FGF23 after six ketamine infusions in adults with depression, indicating that ketamine may mediate a beneficial effect on BMD. The gene discussed is SPP1; the disease is major depressive disorder.